1397PLong-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC). (23rd October 2018) - Crinò, L; Ahn, M-J; Han, J-Y; Liu, X; Ou, S-H I; Shaw, A T; Yang, P-C; Shi, Y-K; Lanzalone, S; Polli, A; Wilner, K D; Kim, D-W